The purpose of this paper is to investigate on the present, innovative and alternative treatment solutions for Diabetes. The main article considered for this essay is – the study by McInnes et al, in 2017, the aim of which was to explore the feasibility, safety as well as potential for bringing about remission from T2D (Type 2 Diabetes) through a limited intensive metabolic treatment . Along with this, other modern means of diabetes treatment would also be explored upon.
It is now an established fact that T2D is a resultant of heredity and environmental factors. Environmental factors like, sedentary lifestyle, and a heavy carbohydrate dependent diet results in the creation of T2D. Bariatric surgeries (Roux-en-Y bypass/ Duodenal Switch/ Gastric Banding etc) also acts as an alternative treatment, which reduces the hypertension, incidence of diabetes etc (Kashyap, Gatmaitan, Brethauer, & Schauer, 2010).
Diabetes is known to impact the kidneys, the eyes and one such complication is diabetic retinopathy, which can be corrected however, through surgery. Pancreas surgery is also possible which keeps the level of insulin adequate in T1D patients. Pancreatic Islet Cell Surgery is another option, which is relatively less complex and gives sufficiently adequate results. Apart from surgery, certain high technological interventions are present which help the patients to consistently monitor the diabetes – CGM, insulin pumps etc.
As per the study by McInnes et al, it was found that a short but crisp course on lifestyle changes and drug therapies achieved normo-glycemia and promoted weight loss. It achieved prolonged, remission of diabetes and is in alignment with the present studies of novel regimens aimed at complete remissions. In this study by McInnes et al, it was found that patients suffering from T2D for 3 years and up, were subjected to three types of treatment – 8 week long intensive medical based interventions; a 16 week long such procedure and thirdly, standard diabetes care which is the norm today. It was found that, weight-loss occurred and normoglycemia was reached. Diabetic drugs like Metformin, Insulin glargine and acarbose were used along with conscious lifestyle changes. The drugs were then discontinued and repeated follow up were done to find relapse of hyperglycemia, but the primary outcome was a normal blood glucose level (McInnes, et al., 2017). Though this study gave very promising results, further and repeated trials has to be continued to bring about an effective treatment strategy and then patients all around the globe can reap its benefits (Bernstein, 2017).
Place Order For A Top Grade Assignment Now
We have some amazing discount offers running for the studentsPlace Your Order
Ali, O. (2013). Genetics of Type 2 Diabetes. World J Diabetes , 4 (4), 114 - 123.
Bernstein, S. (2017). High Tech Tools to Help You Handle Diabetes. US: WebMD https://www.webmd.com/a-to-z-guides/condition-15/diabetes/gadgets.
Kashyap, R., Gatmaitan, P., Brethauer, S., & Schauer, P. (2010). Bariatric Surgey for Type 2 Diabetes - Weighing the impact for obese patients. Cleve Clin J Med , 77 (7), 468 - 476.
McInnes, N., Smith, A., Otto, R., Vandermey, J., Punthakee, Z., Sherifali, D., et al. (2017). Piloting a Remission Strategy in Type 2 Diabetes : Results of a Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism , 102 (5), 1596 - 1605.
Singer, E. (2007). A Genetic Test for Diabetes Risk. US: Technology Review - MIT.
Volpe, D. (2016). FDA Approves Marketing of First ZnT8Ab Auto antibody Assay for Type 1 Diabetes Diagnosis. US: Endocrinoweb https://www.endocrineweb.com/professional/type-1-diabetes/fda-approves-marketing-first-znt8ab-autoantibody-assay-type-1-diabetes-.